Related Experiment Video

Updated: May 19, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

AMPKα2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis

Kathryn N Phoenix1, Charan V Devarakonda, Melissa M Fox

  • 1Department of Cell Biology, Center for Vascular Biology, University of Connecticut Health Center, Farmington, CT, USA.

Genes & Cancer
|August 16, 2012
PubMed

Insights

AMP-activated kinase (AMPK) α2 isoform, not α1, promotes cancer by inhibiting p53. Deleting AMPKα2 increases tumor susceptibility, while AMPKα1 deletion has minimal effects due to compensatory upregulation of AMPKα2.

Area of Science:

  • Cellular metabolism and signaling
  • Cancer biology and tumorigenesis
  • Molecular oncology

Background:

  • AMP-activated kinase (AMPK) is a crucial metabolic sensor regulating cellular energy homeostasis.
  • AMPK isoforms (α1 and α2) have distinct and overlapping functions, with potential roles in tumor suppression.
  • AMPK influences anabolic processes, energy production, cell division, and apoptosis via targets like p53.

Purpose of the Study:

  • To investigate the specific roles of AMPKα1 and AMPKα2 isoforms in cellular transformation and tumorigenesis.
  • To determine the contribution of each AMPKα isoform to Ras-induced transformation and in vivo tumor development.
  • To elucidate the isoform-specific mechanisms by which AMPK affects p53 and controls oncogenic processes.

Main Methods:

  • Generation and analysis of AMPKα1-null and AMPKα2-null murine embryonic fibroblasts (MEFs).
  • Evaluation of susceptibility to H-RasV12-induced transformation in vitro.
  • Assessment of in vivo tumorigenesis and cellular phenotypes including survival, proliferation, and apoptosis.

Main Results:

  • AMPKα2-null MEFs exhibited increased susceptibility to H-RasV12 transformation and in vivo tumorigenesis.
  • AMPKα1-null MEFs showed compensatory upregulation of AMPKα2, leading to reduced transformation susceptibility.
  • AMPKα2 was identified as the isoform selectively responsible for targeting p53, suppressing transformation.

Conclusions:

  • AMPKα2 plays a critical role in suppressing cellular transformation and tumorigenesis, primarily through p53 regulation.
  • Loss of AMPKα2 function enhances susceptibility to oncogenic transformation, while AMPKα1's role is less significant due to compensation.
  • Targeting the AMPKα2 isoform may represent a novel therapeutic strategy for preventing or treating cancer.
Keywords:
AMPKcancerp53transformation

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.